Express Pharma

APRIL 24, 2025

The product is offered in a 4×14 patient-compliant pack with day/night markers and matte foil packaging. per cent dissolution rate, anti-counterfeit Holosec packaging, and competitive pricing at 39.9 per cent dissolution rate, anti-counterfeit Holosec packaging, and competitive pricing at 39.9 The company notes its 98.23

Packaging 85

Packaging Dosage Immunization Immunity 85

pharmaphorum

MARCH 10, 2022

Biologics product development has increased steadily over the past decade, with the volume of business forecast to double by 2030. Driven by advancements in technology, these complex therapeutics have already made waves in life sciences, providing revolutionary treatment options in oncology, immune conditions and rare diseases.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Packaging Immunity 98

PharmaVoice

JUNE 27, 2025

Now, the WHO’s aggressive goal to “ end HIV/AIDS ” by 2030 could be hampered by dramatic reductions in U.S. pharma is facing potential headwinds as the FDA’s attitude toward immunizations shifts under new leadership. million Americans are infected with HIV, but the disease disproportionately impacts people in sub-Saharan Africa.

Vaccines 130

Vaccines Dosage Packaging Immunity 130

Pharmacy Friday Pearls

MARCH 9, 2022

Crotalidae Polyvalent Immune FAB (Ovine). Crofab ® [package insert]. Crotalidae Immune F(ab’)2 (Equine). Anavip ® [package insert]. 2001;161(16):2030-6. Patients can develop delayed or recurrent hematologic symptoms up to a week after treatment cessation, especially following a severe envenomation.

Immunization 40

Immunization Immunity Packaging Labelling 40

pharmaphorum

JUNE 1, 2022

According to the World Health Organization, the world will need more than 40 million new doctors, nurses, frontline healthcare workers, and various other healthcare professionals by 2030. This equates to approximately doubling the current medical workforce. VR for real world education.

Vaccines 145

Vaccines Immunization Immunity Hospitals 145

PharmaTech

JUNE 10, 2025

The global biopharma industry is expected to increase at a compound annual growth rate of 8.97% from 2025 to 2030; this growth is suspected to result from a demand for targeted therapies, new alliances, and increased innovation (1).

Dosage 52

Dosage Drug Development Vaccines Compounding 52